Pricing Log in Create free account

Korro Bio, Inc. (KRRO) vs Tiziana Life Sciences Ltd (TLSA)

Korro Bio, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Korro Bio, Inc. and Tiziana Life Sciences Ltd are of similar size ($137.1M and $134.7M). Across the 8 metrics below, Tiziana Life Sciences Ltd leads on 5 and Korro Bio, Inc. on 3.

Valuation

Metric KRRO TLSA Biotechnology median
P/E n/m n/m 8.42
P/S 25.66 n/m 10.01
P/B 1.59 n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m 0.04 0.61
EV/Sales 10.53 n/m 9.41
Earnings yield (107.41%) (50.37%) (31.85%)
Free cash flow yield (41.62%) 0.00% (24.58%)

Profitability

Metric KRRO TLSA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (97.69%) 0.00% (56.36%)
Return on assets (62.03%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KRRO TLSA Biotechnology median
Revenue growth (TTM) (81.87%) — 6.02%
EPS growth (last fiscal year) (33.19%) (45.45%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.55 0.76 4.72
Net debt to EBITDA 0.64 0.19 0.96

Dividend

Metric KRRO TLSA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric KRRO TLSA Biotechnology median
Market cap 137.09m 134.73m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack